Literature DB >> 2615764

Transcription and messenger RNA processing upstream of bacteriophage T4 gene 32.

A J Carpousis1, E A Mudd, H M Krisch.   

Abstract

Bacteriophage T4 gene 32 lies at the 3' end of a complex transcription unit which includes genes 33, 59, and several open reading frames. In the course of an infection, four major transcripts are synthesized from this unit: two overlapping polycistronic transcripts about 3800 and 2800 nucleotides in length, and two monocistronic gene 32 transcripts about 1150 and 1100 nucleotides in length. These transcripts are made at different times in infection and the polycistronic transcripts have segmental differences in stability. Messenger RNA processing yields a 1025 nucleotide monocistronic gene 32 transcript, and a 135 nucleotide transcript containing part of the gene 59 coding sequence. Processing depends on Escherichia coli encoded ribonuclease E. This pattern of transcription and processing leads to the synthesis of gene 32 mRNA throughout infection, whereas transcripts encoding the upstream genes are present only early in infection. The 3800 nucleotide polycistronic transcript initiates at a promoter that does not require T4 encoded factors for activity. However, full-length synthesis of this transcript depends on the T4 mot gene product. The region upstream of gene 32 also contains four E. coli-like promoters that are active on chimeric plasmids in uninfected cells, but inactive in bacteriophage T4. The location of these cryptic T4 promoters is intriguing in that they lie near the 5' ends of open reading frame B, gene 59 and gene 32. They could play a role in phage development under particular conditions of growth or in bacterial hosts other than those examined here.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615764     DOI: 10.1007/bf00261155

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  45 in total

1.  Reversal of mutant phenotypes by 5-fluorouracil: an approach to nucleotide sequences in messenger-RNA.

Authors:  S P CHAMPE; S BENZER
Journal:  Proc Natl Acad Sci U S A       Date:  1962-04-15       Impact factor: 11.205

2.  A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNA.

Authors:  P X Guo; S Erickson; D Anderson
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

3.  Regulation of the expression of bacteriophage T4 genes 32 and 43.

Authors:  H M Krisch; G Van Houwe; D Belin; W Gibbs; R H Epstein
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  Polypeptide bound to the host RNA polymerase is specified by T4 control gene 33.

Authors:  H R Horvitz
Journal:  Nat New Biol       Date:  1973-08-01

5.  Transcription during bacteriophage T4 development: synthesis and relative stability of early and late RNA.

Authors:  A Bolle; R H Epstein; W Salser; E P Geiduschek
Journal:  J Mol Biol       Date:  1968-02-14       Impact factor: 5.469

6.  Construction and properties of a recombinant plasmid containing gene 32 of bacteriophage T4D.

Authors:  H M Krisch; G B Selzer
Journal:  J Mol Biol       Date:  1981-05-25       Impact factor: 5.469

7.  Nucleotide sequences involved in bacteriophage T4 gene 32 translational self-regulation.

Authors:  H M Krisch; B Allet
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling.

Authors:  R Menzel; M Gellert
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

9.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Inactivation of the ribonucleic acid-processing enzyme ribonuclease E blocks cell division.

Authors:  K Goldblum; D Apririon
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

View more
  17 in total

Review 1.  Processing endoribonucleases and mRNA degradation in bacteria.

Authors:  David Kennell
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

2.  The sequences and activities of RegB endoribonucleases of T4-related bacteriophages.

Authors:  Lina Piesiniene; Lidija Truncaite; Aurelija Zajanckauskaite; Rimas Nivinskas
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

3.  Intermediates in the degradation of mRNA from the lactose operon of Escherichia coli.

Authors:  J R McCormick; J M Zengel; L Lindahl
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

Review 4.  Control of mRNA processing and decay in prokaryotes.

Authors:  P Alifano; C B Bruni; M S Carlomagno
Journal:  Genetica       Date:  1994       Impact factor: 1.082

5.  Gene organization and transcription of a late-expressed region of a Lactococcus lactis phage.

Authors:  R Parreira; R Valyasevi; A L Lerayer; S D Ehrlich; M C Chopin
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

6.  Isolation and development of bioluminescent reporter phages for bacterial dysentery.

Authors:  D A Schofield; D J Wray; I J Molineux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-25       Impact factor: 3.267

Review 7.  Bacteriophage T4 genome.

Authors:  Eric S Miller; Elizabeth Kutter; Gisela Mosig; Fumio Arisaka; Takashi Kunisawa; Wolfgang Rüger
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

8.  The asiA gene product of bacteriophage T4 is required for middle mode RNA synthesis.

Authors:  M Ouhammouch; G Orsini; E N Brody
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

Review 9.  Mobile DNA elements in T4 and related phages.

Authors:  David R Edgell; Ewan A Gibb; Marlene Belfort
Journal:  Virol J       Date:  2010-10-28       Impact factor: 4.099

Review 10.  Transcriptional control in the prereplicative phase of T4 development.

Authors:  Deborah M Hinton
Journal:  Virol J       Date:  2010-10-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.